Europe Smart Life Sciences Manufacturing Market Forecast to 2028
Europe Smart Life Sciences Manufacturing Market Forecast to 2028 – Regional Analysis – by Component (Solutions and Services), Technology [AR/VR Systems, Internet of Things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and Others], Application (Pharma, Bio-Pharma, and Medical Device)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Adoption of Pharma 4.0 Fuel Europe Smart Life Sciences Manufacturing Market
Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the biotechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by biotechnology laboratories.
Modern data analytics tools have allowed biotechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Novozymes, a leading biotechnology company headquartered in Bagsværd, just outside of Copenhagen, Denmark, has adopted Tableau, a data visualization tool, which revolutionized its approach to data analysis and collaboration. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company’s departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes’ sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.
AstraZeneca, plc, a British-Swedish multinational pharmaceutical and biotechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process.
Atomwise has expertise in using AI in small-molecule drug discovery. In December 2021, the company announced its growing portfolio of emerging joint venture companies, with research programs spanning oncology, immunology, infectious disease, neuroscience, and clotting disorders. In the area of infectious disease, the company announced the addition of vAirus, a newly formed joint venture company with world RNA-virus expert Nito Panganiban. The joint venture will use AI-based screening to find small molecule compounds to act as novel broad-spectrum antivirals against flaviviruses. Integrated big data tools such as electronic health records (eHR) can make it easy for healthcare professionals to obtain a comprehensive patient health record, even if information regarding their health originates from scattered sources. Other advances in genetic research backed by big data could lead to dramatic progress in the fight against single-gene disorders, such as sickle cell disease, cystic fibrosis, and hemophilia. This type of research can also be employed to develop improved treatments and prevention strategies for complex conditions such as mental illness and heart disease.
Europe Smart Life Sciences Manufacturing Market Overview
Europe is one of the developed regions for smart life sciences manufacturing, and Industry 4.0 is the fourth revolution started in 2011 by the German government to describe the digital changes in the manufacturing process. The International Society of Pharmaceutical Engineering (ISPE) introduced Pharma 4.0 in 2017, which takes a holistic approach to the implementation of digital technology in pharmaceutical enterprises. The region has seen significant changes in smart life sciences manufacturing owing to the high implementation of smart manufacturing and collaborations among life sciences manufacturers are likely to propel the market growth in Europe in the coming years. In May 2020, Adamed Group, one of the largest pharmaceutical manufacturers in Europe, partnered with Predica for the deployment of Microsoft Azure cloud platform, including security, data analytics, machine learning, and app development. Predica designed and developed a fully extensible platform based on Azure data services and Power BI that helped Adamed generate automated forecasts and optimize its supply chain and marketing decisions. Additionally, in 2022, Hovione, one the Contract Development and Manufacturing Organization (CDMO) from Portugal, collaborated with GEA to advance continuous tableting. This strategic collaboration combines GEA’s engineering expertise with Hovione’s development and manufacturing experience, and both parties commit to partner to accelerate the adoption of continuous tableting technology.
COVID-19 pandemic has increased the adoption and implementation of smart manufacturing technologies, especially for the production of ventilators, hospital beds, drugs, and vaccines. This led to a significant change in the regulatory policies of the region for the production and approval of medical devices and drugs. The European Parliament has replaced medical device directives with regulations. Owing to the pandemic, the manufacturers have amended provisions for the application of regulations in the region. For low-risk devices, the transition period from directive to regulation is extended until May 2027, and for moderate-risk devices, the period is extended until May 2026. Also, the transition period for high-risk devices is extended until May 2025. Digital automation in medical devices helps comply with the regulation and easily process approval, which reduces the approval time and assists in timely product launches. The changing regulatory scenario, high adoption rate of digital technology in life sciences manufacturing, and rising collaborations among market players are expected to augment the Europe smart life sciences manufacturing market growth in Europe during the forecast period.
Europe Smart Life Sciences Manufacturing Market Revenue and Forecast to 2033 (US$ Million)
Europe Smart Life Sciences Manufacturing Market Segmentation
The Europe smart life sciences manufacturing market is segmented into technology, component, application, and country.
Based on component, the Europe smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the Europe smart life sciences manufacturing Market in 2023.
Based on technology, the Europe smart life sciences manufacturing market segment is categorized into AR/VR Systems, Internet of things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of Things segment held the largest share of the Europe smart life sciences manufacturing market in 2023.
Based on application, the Europe smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The medical devices segment held the largest share of the Europe smart life sciences manufacturing market in 2023.
Based on country, the Europe smart life sciences manufacturing market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the Europe smart life sciences manufacturing market in 2023.
ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the Europe smart life sciences manufacturing market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights research, the Europe smart life sciences manufacturing market was valued at US$ 5,679.19 million in 2023 and is expected to reach US$ 22,052.87 million by 2033, registering a CAGR of 14.5% from 2023 to 2033. Rising adoption of Pharma 4.0 and increasing use of technologies in biotechnology laboratories are the critical factors attributed to the Europe smart life sciences manufacturing market.
Pharma 4.0, the fourth industrial revolution, is a holistic approach to the manufacturing of medicinal products. It was introduced by the International Society for Pharmaceutical Engineering (ISPE) in 2017. Advanced automation solutions, modern cloud-based manufacturing execution systems, augmented reality (AR), and cybersecurity are among the major aspects of Pharma 4.0. The goal of Pharma 4.0 is to achieve safer pharmaceutical production with greater efficiency along the whole value chain. It is a highly efficient automated process driven by an integrated manufacturing control strategy.
Artificial intelligence (AI), big data, and machine learning (ML) technologies contribute to highly integrated and autonomous manufacturing systems. The COVID-19 pandemic underlined the insufficiency of paper-based processes in the manufacturing sector across the world. Companies in this sector are looking for having real-time visibility into production processes. The pharmaceutical industry has noticed improvements after the implementation of digital and automation technologies. Many examples have been found in which the process is quite free flow after companies adopting Pharma 4.0.
The primary aim of the collaboration was to enable real-time analytics, make better business decisions, and increase efficiencies across manufacturing processes and supply chains. Additionally, single-use bioprocessing requires low maintenance and has lower operational expenditures. This signifies all biotechnology companies are expected to invest heavily in automation and modern analytics technologies to build technologically advanced smart factories.
The pharmaceutical segment is a key contributor to the industrial sector. Moreover, the demand and sales of medicine are increasing every day. Thus, pharmaceutical manufacturing businesses invest huge amounts of economic resources in R&D for bringing innovations to markets. Technology upgrades are the key to tackling future manufacturing problems.
On the contrary, presence of skill gap and need for high initial investment hampers the Europe smart life sciences manufacturing market.
Based on component, the Europe smart life sciences manufacturing market is bifurcated into solutions and services. The solutions segment held 65.5% share of Europe smart life sciences manufacturing market in 2023, amassing US$ 3,717.17 million. It is projected to garner US$ 13,885.97 million by 2033 to expand at 14.1% CAGR during 2023-2033.
Based on technology, the Europe smart life sciences manufacturing market is segmented into AR/VR Systems, Internet of Things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of Things (IoT) segment held 57.3% share of Europe smart life sciences manufacturing market in 2023, amassing US$ 3,252.47 million. It is projected to garner US$ 11,674.48 million by 2033 to expand at 13.6% CAGR during 2023-2033.
The Cybersecurity segment of the Europe smart life sciences manufacturing market is bifurcated into IT Cybersecurity, and OT Cybersecurity. The OT Cybersecurity segment held 56.3% share of Europe smart life sciences manufacturing market in 2023, amassing US$ 661.78 million. It is projected to garner US$ 2,786.40 million by 2033 to expand at 15.5% CAGR during 2023-2033.
Based on application, the Europe smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical device. The medical device segment held 43.0% share of Europe smart life sciences manufacturing market in 2023, amassing US$ 2,441.15 million. It is projected to garner US$ 9,573.61 million by 2033 to expand at 14.6% CAGR during 2023-2033.
Based on country, the Europe smart life sciences manufacturing market has been categorized into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Our regional analysis states that Germany captured 25.6% share of Europe smart life sciences manufacturing market in 2023. It was assessed at US$ 1,451.50 million in 2023 and is likely to hit US$ 6,347.62 million by 2033, exhibiting a CAGR of 15.9% during 2023-2033.
Key players operating in the Europe smart life sciences manufacturing market are ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Smart Life Sciences Manufacturing Market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe Smart Life Sciences Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Europe Smart Life Sciences Manufacturing Market – By Component
1.3.2 Europe Smart Life Sciences Manufacturing Market – By Technology
1.3.3 Europe Smart Life Sciences Manufacturing Market – By End Use Industry
1.3.4 Europe Smart Life Sciences Manufacturing Market – By Country
2. Europe Smart Life Sciences Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Smart Life Sciences Manufacturing Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion
5. Europe Smart Life Sciences Manufacturing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Adoption of Pharma 4.0
5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
5.2 Market Restraints
5.2.1 Presence of Skill Gap and Need for High Initial Investment
5.3 Market Opportunities
5.3.1 Use of Artificial Intelligence in Cancer Research
5.3.2 Adoption of Virtual Reality in Smart Factory
5.4 Future Trends
5.4.1 Connection to Data Silos
5.4.2 Usage of Blockchain
5.4.3 Edge Computing
5.4.4 Predictive Maintenance
5.4.5 Vision-Based Quality Management
5.4.6 Smart Factory Trends
5.4.7 Emergence of Industry 5.0
5.5 Impact Analysis of Drivers and Restraints
6. Europe Smart Life Sciences Manufacturing Market – Europe Analysis
6.1 Overview
6.2 Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
7. Europe Smart Life Sciences Manufacturing Market Analysis – By Component
7.1 Overview
7.2 Europe Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
7.3 Solutions
7.3.1 Overview
7.3.2 Solutions: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
7.4.1 Overview
7.4.2 Services: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8. Europe Smart Life Sciences Manufacturing Market Analysis – By Technology
8.1 Overview
8.2 Europe Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
8.3 AR/VR System
8.3.1 Overview
8.3.2 AR/VR System: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.4 Internet of Things (IOT)
8.4.1 Overview
8.4.2 Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.5 Artificial Intelligence
8.5.1 Overview
8.5.2 Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.6 Cyber Security
8.6.1 Overview
8.6.2 Cyber Security: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.7 Big Data
8.7.1 Overview
8.7.2 Big Data: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
9. Europe Smart Life Sciences Manufacturing Market Analysis – By End Use Industry
9.1 Overview
9.2 Europe Smart Life Sciences Manufacturing Market, by End Use Industry (2022 and 2033)
9.3 Pharma
9.3.1 Overview
9.3.2 Pharma: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
9.4 Bio-Pharma
9.4.1 Overview
9.4.2 Bio-Pharma: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
9.5 Medical Device
9.5.1 Overview
9.5.2 Medical Device: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
10. Europe Smart Life Sciences Manufacturing Market Analysis – By Country
10.1 Europe Smart Life Sciences Manufacturing Market Overview
10.1.1.1 Germany: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.1.3 Germany: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
10.1.1.1.4 Germany: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
10.1.1.1.4.1 Germany: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
10.1.1.1.5 Germany: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
10.1.1.2 France: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.2.3 France: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
10.1.1.2.4 France: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
10.1.1.2.4.1 France: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
10.1.1.2.5 France: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
10.1.1.3 Italy: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Italy: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.3.3 Italy: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
10.1.1.3.4 Italy: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
10.1.1.3.4.1 Italy: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
10.1.1.3.5 Italy: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
10.1.1.4 UK: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 UK: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.4.3 UK: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
10.1.1.4.4 UK: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
10.1.1.4.4.1 UK: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
10.1.1.4.5 UK: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
10.1.1.5 Spain: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.5.3 Spain: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
10.1.1.5.4 Spain: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
10.1.1.5.4.1 Spain: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
10.1.1.5.5 Spain: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
10.1.1.6 Rest of Europe: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
10.1.1.6.3 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, by Component, 2022-2033 (US$ Million)
10.1.1.6.4 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, by Technology, 2022-2033 (US$ Million)
10.1.1.6.4.1 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type, 2022-2033 (US$ Million)
10.1.1.6.5 Rest of Europe: Europe Smart Life Sciences Manufacturing Market, by End Use Industry, 2022-2033 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Market Initiatives, Expansions, and Strategic Developments
11.3 New Product/Feature Development
11.4 Mergers and Acquisitions
11.5 Agreements, Collaborations, and Joint Ventures
12. Company Profile
12.1 ABB Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bosch Rexroth AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Emerson Electric Co
12.3.1 Business Description
12.3.2 Products and Services
12.3.3 Financial Overview
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 Fortinet Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric Co
12.5.1 Business Description
12.5.2 Products and Services
12.5.3 Financial Overview
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.6 Honeywell International Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 International Business Machines Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Rockwell Automation Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Siemens AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Sophos Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Word Index
LIST OF TABLES
Table 1. Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Table 2. Germany Europe Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 3. Germany Europe Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 4. Germany Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 5. Germany Europe Smart Life Sciences Manufacturing Market, by End Use Industry – Revenue and Forecast to 2033 (US$ Million)
Table 6. France Europe Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 7. France Europe Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 8. France Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 9. France Europe Smart Life Sciences Manufacturing Market, by End Use Industry – Revenue and Forecast to 2033 (US$ Million)
Table 10. Italy Europe Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 11. Italy Europe Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 12. Italy Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 13. Italy Europe Smart Life Sciences Manufacturing Market, by End Use Industry – Revenue and Forecast to 2033 (US$ Million)
Table 14. UK Europe Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 15. UK Europe Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 16. UK Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 17. UK Europe Smart Life Sciences Manufacturing Market, by End Use Industry – Revenue and Forecast to 2033 (US$ Million)
Table 18. Spain Europe Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 19. Spain Europe Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 20. Spain Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 21. Spain Europe Smart Life Sciences Manufacturing Market, by End Use Industry – Revenue and Forecast to 2033 (US$ Million)
Table 22. Rest of Europe Smart Life Sciences Manufacturing Market, by Component – Revenue and Forecast to 2033 (US$ Million)
Table 23. Rest of Europe Smart Life Sciences Manufacturing Market, by Technology – Revenue and Forecast to 2033 (US$ Million)
Table 24. Rest of Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type – Revenue and Forecast to 2033 (US$ Million)
Table 25. Rest of Europe Smart Life Sciences Manufacturing Market, by End Use Industry – Revenue and Forecast to 2033 (US$ Million)
Table 26. List of Abbreviation
LIST OF FIGURES
Figure 1. Europe Smart Life Sciences Manufacturing Market Segmentation
Figure 2. Europe Smart Life Sciences Manufacturing Market Segmentation, By Country
Figure 3. Europe Smart Life Sciences Manufacturing Market Overview
Figure 4. Solutions Held Largest Share of Component Segment in Europe Smart Life Sciences Manufacturing Market
Figure 5. Europe Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Europe Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 10. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
Figure 11. Solutions: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 12. Services: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 13. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
Figure 14. AR/VR System: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 15. Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 16. Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 17. Cyber Security: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 18. Big Data: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 19. Others: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 20. Europe Smart Life Sciences Manufacturing Market Revenue Share, By End Use Industry (2022 and 2033)
Figure 21. Pharma: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 22. Bio-Pharma : Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 23. Medical Device: Europe Smart Life Sciences Manufacturing Market – Revenue, and Forecast to 2033 (US$ Million)
Figure 24. Europe Smart Life Sciences Manufacturing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. Europe Smart Life Sciences Manufacturing Market, Revenue Share, by Key Country, (2022 & 2033)
Figure 26. Germany: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 27. France: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 28. Italy: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 29. UK: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 30. Spain: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
Figure 31. Rest of Europe: Europe Smart Life Sciences Manufacturing Market – Revenue and Forecast to 2033 (US$ Million)
The List of Companies – Europe Smart Life Sciences Manufacturing Market
o ABB Ltd
o Emerson Electric Co
o Fortinet Inc
o General Electric CO
o Honeywell International Inc
o International Business Machines Corp
o Rockwell Automation Inc
o Siemens AG
o Sophos Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.